NVIDIA’s venture arm (NVentures)

Tracked participation in 2 Atlas companies, with 0 explicitly attributed leads.

2portfolio companies

2round participations

0lead positions

Oct 2025latest activity

Capital activity

Portfolio

CompanyLatest valuationFirst → latestRoundsRoleAttributed partner

LSLila SciencesScienceLila Sciences (website: lila.ai) builds what it calls an “operating system for science,” combining an AI reasoning…$1.3Bvaluation$1.1BraisedRecent roundsSeries A extension (NVIDIA-backed) · Oct 2025$115M · Abu Dhabi Investment Authority (ADIA) (subsidiary), Flagship Pioneering +2Series A · Oct 2025$350M · led by Braidwell, Collective GlobalSeed · Oct 2025$200M · Abu Dhabi Investment Authority (ADIA) subsidiary, Altitude Life Science Ventures +7Lila Sciences$1.3BOct 2025 → Oct 20251 roundParticipant—

RTRelation Therapeutics—Mar 2024 → Mar 20241 roundParticipant—

DateCompanyRoundRaisedValuationRoleEvidence

Oct 14, 2025LSLila SciencesScienceLila Sciences (website: lila.ai) builds what it calls an “operating system for science,” combining an AI reasoning…$1.3Bvaluation$1.1BraisedRecent roundsSeries A extension (NVIDIA-backed) · Oct 2025$115M · Abu Dhabi Investment Authority (ADIA) (subsidiary), Flagship Pioneering +2Series A · Oct 2025$350M · led by Braidwell, Collective GlobalSeed · Oct 2025$200M · Abu Dhabi Investment Authority (ADIA) subsidiary, Altitude Life Science Ventures +7Lila SciencesSeries A extension (NVIDIA-backed)$115M$1.3BParticipant

Source ↗

Mar 14, 2024RTRelation Therapeuticsseed (extension/new seed)$35M—Participant

Source ↗+1 ↗

DateCompanyRoundRaisedValuationRoleEvidence

Source ↗

Mar 14, 2024RTRelation Therapeuticsseed (extension/new seed)$35M—Participant

Source ↗+1 ↗